Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Daniel Fantus"'
Autor:
Ian Carrigan, Sunita Mathur, Nicholas Bourgeois, Mélanie Dieudé, Daniel Fantus, Patricia Gongal, Anne Halpin, Alim Hirji, Holly Mansell, Caroline Piotrowski, Ruth Sapir-Pichhadze, Amanda J. Vinson
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 10 (2023)
Purpose of the Conference: The 2022 Banff-Canadian Society of Transplantation Meeting in Banff, Alberta, brought together transplant professionals to review new developments across various aspects of solid organ transplantation (SOT) in Canada. Sourc
Externí odkaz:
https://doaj.org/article/4fda511d34ab405d9496f2352f6d58bf
Autor:
Julie Ho, Stefan Schaub, Annette M. Jackson, Robert Balshaw, Robert Carroll, Sylvia Cun, Sacha A. De Serres, Daniel Fantus, Joelle Handschin, Gideon Hönger, Anthony M. Jevnikar, Marc Kleiser, Jar-How Lee, Yan Li, Peter Nickerson, Rui Pei, Denise Pochinco, Remi Shih, Michael Trinh, Jason Wang, Julie Nguyen, Stuart Knechtle
Publikováno v:
Transplantation.
Autor:
Kenneth Litchfield, Lianne Barnieh, Marian Reich, Ngan N. Lam, Susan McKenzie, Seychelle Yohanna, Ann Bugeja, Istvan Mucsi, Amit X. Garg, Steven Habbous, Daniel Fantus, Jagbir Gill, Kate Chong, G. V. Ramesh Prasad, Rahul Mainra, Christine Dipchand, Leah Getchell
Publikováno v:
Clinical Journal of the American Society of Nephrology. 15:1464-1473
Background and objectives Many patients, providers, and potential living donors perceive the living kidney donor evaluation process to be lengthy and difficult to navigate. Design, setting, participants, & measurements We sought consensus on key term
Autor:
Michel Pâquet, Daniel Fantus
Publikováno v:
CMAJ
Many transplant centres have temporarily shut down their living donor kidney transplant programs “to ease pressure on hospitals and protect donors and recipients from coronavirus disease 2019 (COVID-19).”[1][1] These actions make sense. At the sa
Publikováno v:
British Journal of Clinical Pharmacology. 82:1158-1170
The macrolide rapamycin and its analogues (rapalogs) constitute the first generation of mammalian target of rapamycin (mTOR) inhibitors. Since the introduction of rapamycin as an immunosuppressant, there has been extensive progress in understanding i
Autor:
Natasha M. Rogers, Angus W. Thomson, Alicia R. Watson, Longkai Peng, Daniel Fantus, Helong Dai
Publikováno v:
Kidney international. 94(5)
Dendritic cells (DC) are critical initiators of innate immunity in the kidney and orchestrate inflammation following ischemia-reperfusion injury. The role of the mammalian/mechanistic target of rapamycin (mTOR) in the pathophysiology of renal ischemi
Autor:
Alicia R. Watson, Natasha M. Rogers, Helong Dai, Longkai Peng, Daniel Fantus, Angus W. Thomson
Publikováno v:
Transplantation. 102:S171-S172
Publikováno v:
Atherosclerosis. 226:9-15
Once thought to be a passive process of calcium accrual in arterial vascular beds, vascular calcification is considered to be a tightly regulated process mediated by osteoblast-like cells under the dys-regulated interplay of shear stress, metabolites
Publikováno v:
Nature reviews. Nephrology. 12(10)
The mTOR pathway has a central role in the regulation of cell metabolism, growth and proliferation. Studies involving selective gene targeting of mTOR complexes (mTORC1 and mTORC2) in renal cell populations and/or pharmacologic mTOR inhibition have r
Autor:
Maxim A. Skabkin, Yuri V. Svitkin, Ann Brasey, Lev P. Ovchinnikov, Valentina Evdokimova, Akiko Yanagiya, Tatyana V. Pestova, Daniel Fantus, Nahum Sonenberg, William C. Merrick, Hiroaki Imataka
Publikováno v:
The EMBO Journal. 28:58-68
The interaction between the poly(A)-binding protein (PABP) and eukaryotic translational initiation factor 4G (eIF4G), which brings about circularization of the mRNA, stimulates translation. General RNA-binding proteins affect translation, but their r